Sessions’ new ‘war on drugs’ is ‘war on people’ says National LGBTQ Task Force

WASHINGTON, D.C., —In a backward move and a major turnabout from the policies of Obama administration Attorneys General Eric Holder and Loretta Lynch, Trump Attorney General Jeff Sessions has directed federal prosecutors to pursue the harshest criminal penalties for those who have been charged with drug crimes. The move is being described by the National LGBTQ…

Read More

More than 150 organizations demand that Turing Pharmaceuticals lower cost of life-saving drug

Today, the Human Rights Campaign (HRC) joined 151 other organizations from across the nation in signing an open letter to Turing Pharmaceuticals urging company CEO Martin Shkreli to immediately act on his promise to lower the price on Daraprim — a crucial and often lifesaving treatment for those living with HIV. “Physicians are reporting that…

Read More

Bernie Sanders gives Turing Pharmaceuticals CEO’s donation to an HIV Clinic

Democratic presidential hopeful Bernie Sanders has given the donation of a pharmaceutical CEO who controversially raised the price of an AIDS medication to a Washington, D.C.-based clinic that specializes in the treatment of HIV patients and the LGBT community, reports The Advocate. Martin Shkreli, the CEO of Turing Pharmaceuticals, had donated $2,700 to the Sanders…

Read More

New York Attorney General launches antitrust inquiry into Turing Pharmaceuticals’ distribution practices

WASHINGTON — Today, at the urging of the Human Rights Campaign (HRC), the New York attorney general has begun investigating whether Turing Pharmaceuticals, which recently imposed an unconscionable 5,000 percent price hike on the life-saving drug Daraprim, may have violated antitrust laws by limiting its distribution. Chad Griffin, President of HRC, the nation’s largest lesbian,…

Read More

HRC calls on Turing CEO to lower price on HIV drug

WASHINGTON – Today, the Human Rights Campaign (HRC) once again called on Turing Pharmaceuticals CEO Martin Shkreli to make good on his unfulfilled promise of Sept. 22 to lower the price on Daraprim — a crucial and often lifesaving treatment for those living with HIV — and urged officials to expeditiously investigate Turing’s reckless overnight 5,000…

Read More

AHF: FDA commissioner nominee is ‘Too close for comfort’ to drug industry

LOS ANGELES — Friday AIDS Healthcare Foundation (AHF) President Michael Weinstein released the following statement on President Obama nominating cardiologist Dr. Robert M. Califf to head the U.S. Food and Drug Administration (FDA): “While Dr. Califf’s contributions to the research and clinical science community are well known and commendable, his cozy relationship with the pharmaceutical…

Read More

AHF: $750 drug that sells for $1 to government agencies underscores need for drug pricing reform

LOS ANGELES —AIDS Healthcare Foundation (AHF), the largest global AIDS organization that currently serves over 486,000 patients around the world each year, today denounced the lack of regulation and pharmaceutical industry greed that has led to record drug prices for specialty medications and billions of dollars in profits for drug manufacturers.  Most recently, Turing Pharmaceuticals…

Read More

amfAR report examines controversial pricing of hepatitis C treatment

NEW YORK  – Despite important price reductions for some low- and middle-income countries, the exorbitant drug pricing of breakthrough treatments for hepatitis C (HCV) infection will inevitably limit access to the drugs, leading to unnecessary loss of life, according to a new report from amfAR, The Foundation for AIDS Research. While the new drugs have…

Read More
CDC

New CDC guidelines recommend daily HIV prevention pill for those at substantial risk

Health care providers should consider advising the use of anti-HIV drugs by uninfected patients who are at substantial risk of infection, according to new clinical guidelines, released by Centers of Disease Control and Prevention (CDC). PrEP, or pre-exposure prophylaxis, could reduce HIV infection rates. When taken daily as directed, PrEP can reduce the risk of…

Read More